CRYSTALLINE FORM OF THE COMPOUND (S)-3-{4-[5-(2-CYCLOPENTYL-6-METHOXY-PYRIDIN-4-YL)-[1,2,4]OXADIAZOL-3-YL]-2-ETHYL-6-METHYL-PHENOXY}-PROPANE-1,2-DIOL
Abstract The present invention relates to a crystalline form of the compound (S)-3-{445-(2-cyclopentyl-6-methoxy-pyridin-4-yl)41,2 ,4]oxadiazol-3-yl]-2-ethyl-6-m ethyl-phenoxyy propane-1 ,2-diol characterized by the presence of peaks in the X-ray powder diffraction diagram at the following angles of...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | Abstract The present invention relates to a crystalline form of the compound (S)-3-{445-(2-cyclopentyl-6-methoxy-pyridin-4-yl)41,2 ,4]oxadiazol-3-yl]-2-ethyl-6-m ethyl-phenoxyy propane-1 ,2-diol characterized by the presence of peaks in the X-ray powder diffraction diagram at the following angles of refraction 20: 5.4 , 8.5 , and 10.8 Date Recue/Date Received 2020-09-29
La présente invention concerne une forme cristalline du composé (S)-3-{4- [5-(2-cyclopentyl-6-méthoxy-pyridin-4-yl)-[1,2,4] oxadiazol-3-yl]-2-éthyl-6-méthyl-phénoxy}-propane-1,2-diol. |
|---|